Hennessy BT - Search Results

1

Pharmacodynamic markers of perifosine efficacy.

Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Hennessy BT, et al. Clin Cancer Res. 2007 Dec 15;13(24):7421-31. doi: 10.1158/1078-0432.CCR-07-0760. Clin Cancer Res. 2007. PMID: 18094426

2

Exploiting the PI3K/AKT pathway for cancer drug discovery.

Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Hennessy BT, et al. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004. doi: 10.1038/nrd1902. Nat Rev Drug Discov. 2005. PMID: 16341064 Review.

3

Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics.

Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN. Hennessy BT, et al. Nat Clin Pract Oncol. 2005 Dec;2(12):598-9. doi: 10.1038/ncponc0375. Nat Clin Pract Oncol. 2005. PMID: 16341096 No abstract available.

4

Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer.

Hennessy BT, Nanjundan M, Cheng KW, Nolden L, Mills GB. Hennessy BT, et al. Eur J Hum Genet. 2006 Apr;14(4):381-3. doi: 10.1038/sj.ejhg.5201570. Eur J Hum Genet. 2006. PMID: 16418735 No abstract available.

5

Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.

Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M, Kau SW, Broglio K, Fornage B, Singletary SE, Sahin A, Buzdar AU, Valero V. Hennessy BT, et al. Cancer. 2006 Mar 1;106(5):1000-6. doi: 10.1002/cncr.21726. Cancer. 2006. PMID: 16444747 Free article. Clinical Trial.

6

Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.

Hennessy BT, Mills GB. Hennessy BT, et al. Int J Biochem Cell Biol. 2006;38(9):1450-6. doi: 10.1016/j.biocel.2006.01.009. Epub 2006 Feb 21. Int J Biochem Cell Biol. 2006. PMID: 16682246 Review.

7

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Stemke-Hale K, Hennessy B, Mills GB, Mitra R. Stemke-Hale K, et al. Curr Oncol Rep. 2006 Nov;8(6):484-91. doi: 10.1007/s11912-006-0078-5. Curr Oncol Rep. 2006. PMID: 17040626 Review.

8

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, Kornblau SM. Tibes R, et al. Mol Cancer Ther. 2006 Oct;5(10):2512-21. doi: 10.1158/1535-7163.MCT-06-0334. Mol Cancer Ther. 2006. PMID: 17041095

9

Point mutations of protein kinases and individualised cancer therapy.

Davies M, Hennessy B, Mills GB. Davies M, et al. Expert Opin Pharmacother. 2006 Nov;7(16):2243-61. doi: 10.1517/14656566.7.16.2243. Expert Opin Pharmacother. 2006. PMID: 17059381 Review.

10

The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.

Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB. Liang J, et al. Nat Cell Biol. 2007 Feb;9(2):218-24. doi: 10.1038/ncb1537. Epub 2007 Jan 21. Nat Cell Biol. 2007. PMID: 17237771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page